Maternal ancestry and hematological cancer risk: case-control study in an Argentinean population.

We investigated the role of maternal ancestry in neoplastic hematological malignancies (HMs) risk in a population from Central Argentina. We analyzed 125 cases with HMs and 310 controls from a public hospital, and a set of 202 colorectal, breast, lung, and hematologic cancer patients from a private hospital. A decreased risk for HMs was associated with the Native American haplogroup B2 (odds ratio = 0.